For the person who is paying attention
You're scared. You're watching what's happening to them and you're wondering if that's your future too. That fear is completely rational — and it means you're already ahead of most people.
I'm Jess. I've been a dementia specialist for 30 years. I've sat with thousands of families in the exact place you're in right now — watching a parent decline, wondering what it means for them, wondering what it means for you.
Here's what I wish someone had told me earlier in my career: the people who do best — the ones who slow progression, who stay sharp into their 80s and 90s, who genuinely outsmart their genetics — are the ones who started paying attention before they had symptoms. Not after.
You're already doing that. The question is what to do next.
I hear this constantly. And I understand why doctors say it — most clinical Alzheimer's testing has age minimums, and doctors are cautious. But here's what they're not telling you: you can check your APOE genotype at home, right now, for under $50. This isn't a diagnosis. It's a risk profile — like knowing your cholesterol. And knowing your APOE status at 45 gives you 20 years of runway to act on it. Waiting until 65 gives you almost none.
This is a legitimate concern and I won't dismiss it. GINA (the Genetic Information Nondiscrimination Act) protects you from discrimination in health insurance and employment — but it does not cover life insurance or long-term care insurance. Here's the workaround: at-home APOE testing through a direct-to-consumer kit does not go into your medical record. You order it, you get the result, it stays between you and the kit. No doctor's office, no insurance company, no record.
I respect this perspective. For some people, not knowing genuinely is the right choice. But I'd ask you this: is the not knowing actually making you less anxious right now? Or is it just making the anxiety vague and shapeless instead of specific and actionable? Most of the people I've worked with who chose to test said the same thing afterward: "I thought knowing would be worse. It wasn't. It gave me something to do." Knowledge, for most people, is less scary than the dark.
This one I push back on hard. Thirty years ago, this was closer to true. Today it isn't. APOE4 is the most common genetic risk factor for late-onset Alzheimer's — but it is not a sentence. There are APOE4 carriers in their 80s and 90s with no cognitive decline. The research on what separates them from those who do decline is growing every year. Diet, sleep, inflammation, specific supplements, stress management, metabolic health — these things matter enormously for APOE4 carriers. The gene loads the gun. Your lifestyle decides whether it fires.
Both paths lead to real help. Choose the one that fits where you are today.
You're not in crisis yet. You're paying attention. You want to know your APOE status, understand what it means, and build a protocol to protect your brain before symptoms ever start. This is the proactive path — and it's the most powerful one.
Hack Your APOE4 →At-home testing · Genotype-specific protocols · APOE4 community
Your loved one already has dementia and you're the one holding everything together. You need practical, specific guidance — not generic advice. The CALM Home Protocol is built for exactly this: the caregiver who's exhausted, scared, and needs something that actually works.
The CALM Home Protocol →Free guides · Behavior protocols · Caregiver support
"I built both of these resources because I kept watching the same thing happen: families getting blindsided. A parent diagnosed, and suddenly everyone is scrambling — the adult children wondering if they're next, the caregiver drowning with no roadmap. I wanted to build something that catches people before the scramble. If you're reading this, you're already ahead. Don't waste that."
Jess Taylor
30-Year Dementia Specialist · Certified Dementia Practitioner · APOE4 Independent Researcher
That's the first step. The second step is picking a path and taking one action today — not everything, just one thing.